Incannex Healthcare Inc.
IXHL · XNASCIK 1873875fmd_1PSY85T1RWFR0M3T7M1EZ01NGEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2019 to Sep 30, 2026, 20 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 2 | – | – | 0 | 0 | 0 |
| Rental revenue | – | – | – | – | 0 | – | – |
| Cost of revenue | 0 | 1 | 0 | – | – | – | – |
| Gross profit | 0 | 1 | – | – | – | – | – |
| Research and development | 2 | 5 | 5 | 6 | 13 | 11 | 5 |
| Total operating expenses | – | – | – | 50 | 30 | 24 | 23 |
| Operating income | – | – | – | (50) | (30) | (24) | (23) |
| Interest expense | – | – | – | – | – | 0 | 0 |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | 1 | 12 | (23) | 4 |
| Income before taxes | (4) | (11) | (15) | (49) | (18) | (47) | (19) |
| Income tax expense | – | – | – | – | 0 | 0 | 0 |
| Net income from continuing operations | (4) | (11) | (15) | (20) | (18) | (47) | (19) |
| Net income | (5) | (11) | (15) | (49) | (18) | (47) | (19) |